Follow the people · Insider
Alan J. Russell
Alan J. Russell files insider transactions with the SEC as a chief scientific officer of Edgewise Therapeutics (EWTX). We hold 2 disclosed purchases and sales filed since 19 August 2021, 2 of them in the last 90 days.
- Files forEWTX
- Disclosed buys and sells2 in all, 2 in the last 90 days
- Last disclosure14 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 17 August 2021 — 12 August 2026Chief Scientific Officer · Edgewise Therapeutics (EWTX)99 Form 4 lines · source: SEC Form 4
Everything they disclosed
99 entries, newest first — one per disclosure report, one per Form 4 line- was granted 65,000 shares of Edgewise Therapeutics (a derivative holding)SEC Form 417 August 2026Stock Option (Right to Buy) · traded 12 August 2026 · filed 17 August 2026
- exercised options over 5,781 shares of Edgewise TherapeuticsSEC Form 414 August 2026Common Stock · traded 12 August 2026 · filed 14 August 2026
- exercised options over 7,031 shares of Edgewise TherapeuticsSEC Form 414 August 2026Common Stock · traded 12 August 2026 · filed 14 August 2026
- ▼ sold on the open market 3,238 shares of Edgewise TherapeuticsSEC Form 414 August 2026Common Stock · traded 12 August 2026 · filed 14 August 2026
- ▼ sold on the open market 2,273 shares of Edgewise TherapeuticsSEC Form 414 August 2026Common Stock · traded 12 August 2026 · filed 14 August 2026
- ▼ sold on the open market 390 shares of Edgewise TherapeuticsSEC Form 414 August 2026Common Stock · traded 12 August 2026 · filed 14 August 2026
- exercised options over 5,781 shares of Edgewise Therapeutics (a derivative holding)SEC Form 414 August 2026Restricted Stock Units · traded 12 August 2026 · filed 14 August 2026
- exercised options over 7,031 shares of Edgewise Therapeutics (a derivative holding)SEC Form 414 August 2026Restricted Stock Units · traded 12 August 2026 · filed 14 August 2026
- was granted 32,500 shares of Edgewise Therapeutics (a derivative holding)SEC Form 414 August 2026Restricted Stock Units · traded 12 August 2026 · filed 14 August 2026
- was granted 65,000 shares of Edgewise Therapeutics (a derivative holding)SEC Form 414 August 2026Stock Option (Right to Buy) · traded 12 August 2026 · filed 14 August 2026
- exercised options over 130,352 shares of Edgewise TherapeuticsSEC Form 42 July 2026Common Stock · traded 1 July 2026 · filed 2 July 2026
- exercised options over 69,648 shares of Edgewise TherapeuticsSEC Form 42 July 2026Common Stock · traded 1 July 2026 · filed 2 July 2026
- ▼ sold on the open market 130,352 shares of Edgewise TherapeuticsSEC Form 42 July 2026Common Stock · traded 1 July 2026 · filed 2 July 2026
- ▼ sold on the open market 69,648 shares of Edgewise TherapeuticsSEC Form 42 July 2026Common Stock · traded 1 July 2026 · filed 2 July 2026
- exercised options over 130,352 shares of Edgewise Therapeutics (a derivative holding)SEC Form 42 July 2026Stock Option (Right to Buy) · traded 1 July 2026 · filed 2 July 2026
- exercised options over 69,648 shares of Edgewise Therapeutics (a derivative holding)SEC Form 42 July 2026Stock Option (Right to Buy) · traded 1 July 2026 · filed 2 July 2026
- exercised options over 100,000 shares of Edgewise Therapeutics (a derivative holding)SEC Form 413 November 2025Stock Option (Right to Buy) · traded 12 November 2025 · filed 13 November 2025
- exercised options over 100,000 shares of Edgewise TherapeuticsSEC Form 413 November 2025Common Stock · traded 12 November 2025 · filed 13 November 2025
- ▼ sold on the open market 100,000 shares of Edgewise TherapeuticsSEC Form 413 November 2025Common Stock · traded 12 November 2025 · filed 13 November 2025
- exercised options over 100,000 shares of Edgewise Therapeutics (a derivative holding)SEC Form 428 August 2025Stock Option (Right to Buy) · traded 26 August 2025 · filed 28 August 2025
- exercised options over 100,000 shares of Edgewise TherapeuticsSEC Form 428 August 2025Common Stock · traded 26 August 2025 · filed 28 August 2025
- ▼ sold on the open market 100,000 shares of Edgewise TherapeuticsSEC Form 428 August 2025Common Stock · traded 26 August 2025 · filed 28 August 2025
- exercised options over 5,781 shares of Edgewise Therapeutics (a derivative holding)SEC Form 414 August 2025Restricted Stock Units · traded 12 August 2025 · filed 14 August 2025
- was granted 28,125 shares of Edgewise Therapeutics (a derivative holding)SEC Form 414 August 2025Restricted Stock Units · traded 12 August 2025 · filed 14 August 2025
- was granted 168,750 shares of Edgewise Therapeutics (a derivative holding)SEC Form 414 August 2025Stock Option (Right to Buy) · traded 12 August 2025 · filed 14 August 2025
- exercised options over 5,781 shares of Edgewise TherapeuticsSEC Form 414 August 2025Common Stock · traded 12 August 2025 · filed 14 August 2025
- ▼ sold on the open market 1,907 shares of Edgewise TherapeuticsSEC Form 414 August 2025Common Stock · traded 12 August 2025 · filed 14 August 2025
- exercised options over 5,209 shares of Edgewise Therapeutics (a derivative holding)SEC Form 47 May 2025Restricted Stock Units · traded 1 May 2025 · filed 7 May 2025
- exercised options over 5,209 shares of Edgewise TherapeuticsSEC Form 47 May 2025Common Stock · traded 1 May 2025 · filed 7 May 2025
- ▼ sold on the open market 1,551 shares of Edgewise TherapeuticsSEC Form 47 May 2025Common Stock · traded 2 May 2025 · filed 7 May 2025
- exercised options over 200 shares of Edgewise Therapeutics (a derivative holding)SEC Form 411 March 2025Stock Option (Right to Buy) · traded 7 March 2025 · filed 11 March 2025
- exercised options over 200 shares of Edgewise TherapeuticsSEC Form 411 March 2025Common Stock · traded 7 March 2025 · filed 11 March 2025
- ▼ sold on the open market 200 shares of Edgewise TherapeuticsSEC Form 411 March 2025Common Stock · traded 7 March 2025 · filed 11 March 2025
- exercised options over 8,015 shares of Edgewise Therapeutics (a derivative holding)SEC Form 47 February 2025Stock Option (Right to Buy) · traded 5 February 2025 · filed 7 February 2025
- exercised options over 1,200 shares of Edgewise Therapeutics (a derivative holding)SEC Form 47 February 2025Stock Option (Right to Buy) · traded 6 February 2025 · filed 7 February 2025
- exercised options over 8,015 shares of Edgewise TherapeuticsSEC Form 47 February 2025Common Stock · traded 5 February 2025 · filed 7 February 2025
- ▼ sold on the open market 8,015 shares of Edgewise TherapeuticsSEC Form 47 February 2025Common Stock · traded 5 February 2025 · filed 7 February 2025
- exercised options over 1,200 shares of Edgewise TherapeuticsSEC Form 47 February 2025Common Stock · traded 6 February 2025 · filed 7 February 2025
- ▼ sold on the open market 1,200 shares of Edgewise TherapeuticsSEC Form 47 February 2025Common Stock · traded 6 February 2025 · filed 7 February 2025
- exercised options over 100,000 shares of Edgewise Therapeutics (a derivative holding)SEC Form 431 December 2024Stock Option (Right to Buy) · traded 30 December 2024 · filed 31 December 2024
- exercised options over 100,000 shares of Edgewise TherapeuticsSEC Form 431 December 2024Common Stock · traded 30 December 2024 · filed 31 December 2024
- ▼ sold on the open market 100,000 shares of Edgewise TherapeuticsSEC Form 431 December 2024Common Stock · traded 30 December 2024 · filed 31 December 2024
- exercised options over 75,000 shares of Edgewise Therapeutics (a derivative holding)SEC Form 424 September 2024Stock Option (Right to Buy) · traded 20 September 2024 · filed 24 September 2024
- exercised options over 75,000 shares of Edgewise TherapeuticsSEC Form 424 September 2024Common Stock · traded 20 September 2024 · filed 24 September 2024
- ▼ sold on the open market 74,185 shares of Edgewise TherapeuticsSEC Form 424 September 2024Common Stock · traded 20 September 2024 · filed 24 September 2024
- ▼ sold on the open market 815 shares of Edgewise TherapeuticsSEC Form 424 September 2024Common Stock · traded 20 September 2024 · filed 24 September 2024
- was granted 138,750 shares of Edgewise Therapeutics (a derivative holding)SEC Form 414 August 2024Stock Option (Right to Buy) · traded 12 August 2024 · filed 14 August 2024
- was granted 23,125 shares of Edgewise Therapeutics (a derivative holding)SEC Form 414 August 2024Restricted Stock Units · traded 12 August 2024 · filed 14 August 2024
- exercised options over 5,208 shares of Edgewise Therapeutics (a derivative holding)SEC Form 43 May 2024Restricted Stock Units · traded 1 May 2024 · filed 3 May 2024
- exercised options over 5,208 shares of Edgewise TherapeuticsSEC Form 43 May 2024Common Stock · traded 1 May 2024 · filed 3 May 2024
- ▼ sold on the open market 1,576 shares of Edgewise TherapeuticsSEC Form 43 May 2024Common Stock · traded 2 May 2024 · filed 3 May 2024
- ▼ sold on the open market 172,585 shares of Edgewise TherapeuticsSEC Form 428 December 2023Common Stock · traded 26 December 2023 · filed 28 December 2023
- was granted 200,000 shares of Edgewise Therapeutics (a derivative holding)SEC Form 418 August 2023Stock Option (Right to Buy) · traded 17 August 2023 · filed 18 August 2023
- exercised options over 5,208 shares of Edgewise Therapeutics (a derivative holding)SEC Form 43 May 2023Restricted Stock Units · traded 1 May 2023 · filed 3 May 2023
- exercised options over 5,208 shares of Edgewise TherapeuticsSEC Form 43 May 2023Common Stock · traded 1 May 2023 · filed 3 May 2023
- ▼ sold on the open market 1,602 shares of Edgewise TherapeuticsSEC Form 43 May 2023Common Stock · traded 2 May 2023 · filed 3 May 2023
- was granted 220,000 shares of Edgewise Therapeutics (a derivative holding)SEC Form 410 August 2022Stock Option (Right to Buy) · traded 8 August 2022 · filed 10 August 2022
- was granted 15,625 shares of Edgewise Therapeutics (a derivative holding)SEC Form 43 May 2022Restricted Stock Units · traded 1 May 2022 · filed 3 May 2022
- exercised options over 147,585 shares of EWTX (a derivative holding)SEC Form 41 December 2021Stock Option (Right to Buy) · traded 30 November 2021 · filed 1 December 2021
- exercised options over 25,000 shares of EWTX (a derivative holding)SEC Form 41 December 2021Stock Option (Right to Buy) · traded 30 November 2021 · filed 1 December 2021
- exercised options over 147,585 shares of EWTXSEC Form 41 December 2021Common Stock · traded 30 November 2021 · filed 1 December 2021
- exercised options over 25,000 shares of EWTXSEC Form 41 December 2021Common Stock · traded 30 November 2021 · filed 1 December 2021
- ▼ sold on the open market 441 shares of Edgewise TherapeuticsSEC Form 417 November 2021Common Stock · traded 15 November 2021 · filed 17 November 2021
- ▼ sold on the open market 38 shares of Edgewise TherapeuticsSEC Form 417 November 2021Common Stock · traded 15 November 2021 · filed 17 November 2021
- ▼ sold on the open market 16,864 shares of Edgewise TherapeuticsSEC Form 412 November 2021Common Stock · traded 9 November 2021 · filed 12 November 2021
- ▼ sold on the open market 12,712 shares of Edgewise TherapeuticsSEC Form 412 November 2021Common Stock · traded 9 November 2021 · filed 12 November 2021
- ▼ sold on the open market 11,746 shares of Edgewise TherapeuticsSEC Form 412 November 2021Common Stock · traded 10 November 2021 · filed 12 November 2021
- ▼ sold on the open market 580 shares of Edgewise TherapeuticsSEC Form 412 November 2021Common Stock · traded 10 November 2021 · filed 12 November 2021
- ▼ sold on the open market 15,595 shares of Edgewise TherapeuticsSEC Form 412 November 2021Common Stock · traded 11 November 2021 · filed 12 November 2021
- ▼ sold on the open market 3,681 shares of Edgewise TherapeuticsSEC Form 412 November 2021Common Stock · traded 11 November 2021 · filed 12 November 2021
- ▼ sold on the open market 8,562 shares of Edgewise TherapeuticsSEC Form 412 November 2021Common Stock · traded 12 November 2021 · filed 12 November 2021
- ▼ sold on the open market 7,392 shares of Edgewise TherapeuticsSEC Form 48 November 2021Common Stock · traded 4 November 2021 · filed 8 November 2021
- ▼ sold on the open market 6 shares of Edgewise TherapeuticsSEC Form 48 November 2021Common Stock · traded 5 November 2021 · filed 8 November 2021
- ▼ sold on the open market 13,036 shares of Edgewise TherapeuticsSEC Form 48 November 2021Common Stock · traded 5 November 2021 · filed 8 November 2021
- ▼ sold on the open market 9,017 shares of Edgewise TherapeuticsSEC Form 48 November 2021Common Stock · traded 8 November 2021 · filed 8 November 2021
- ▼ sold on the open market 469 shares of Edgewise TherapeuticsSEC Form 43 November 2021Common Stock · traded 1 November 2021 · filed 3 November 2021
- ▼ sold on the open market 17,519 shares of Edgewise TherapeuticsSEC Form 43 November 2021Common Stock · traded 2 November 2021 · filed 3 November 2021
- ▼ sold on the open market 20,822 shares of Edgewise TherapeuticsSEC Form 43 November 2021Common Stock · traded 3 November 2021 · filed 3 November 2021
- ▼ sold on the open market 4,243 shares of Edgewise TherapeuticsSEC Form 43 November 2021Common Stock · traded 3 November 2021 · filed 3 November 2021
- ▼ sold on the open market 1,119 shares of Edgewise TherapeuticsSEC Form 43 November 2021Common Stock · traded 3 November 2021 · filed 3 November 2021
- ▼ sold on the open market 5,749 shares of Edgewise TherapeuticsSEC Form 418 October 2021Common Stock · traded 14 October 2021 · filed 18 October 2021
- ▼ sold on the open market 1,307 shares of Edgewise TherapeuticsSEC Form 418 October 2021Common Stock · traded 15 October 2021 · filed 18 October 2021
- ▼ sold on the open market 126 shares of Edgewise TherapeuticsSEC Form 418 October 2021Common Stock · traded 15 October 2021 · filed 18 October 2021
- ▼ sold on the open market 1,270 shares of Edgewise TherapeuticsSEC Form 413 October 2021Common Stock · traded 11 October 2021 · filed 13 October 2021
- ▼ sold on the open market 2,108 shares of Edgewise TherapeuticsSEC Form 48 October 2021Common Stock · traded 6 October 2021 · filed 8 October 2021
- ▼ sold on the open market 13,018 shares of Edgewise TherapeuticsSEC Form 48 October 2021Common Stock · traded 7 October 2021 · filed 8 October 2021
- ▼ sold on the open market 5,902 shares of Edgewise TherapeuticsSEC Form 48 October 2021Common Stock · traded 8 October 2021 · filed 8 October 2021
- ▼ sold on the open market 274 shares of Edgewise TherapeuticsSEC Form 45 October 2021Common Stock · traded 1 October 2021 · filed 5 October 2021
- ▼ sold on the open market 100 shares of Edgewise TherapeuticsSEC Form 45 October 2021Common Stock · traded 4 October 2021 · filed 5 October 2021
- ▼ sold on the open market 5,404 shares of Edgewise TherapeuticsSEC Form 45 October 2021Common Stock · traded 5 October 2021 · filed 5 October 2021
- ▼ sold on the open market 14,610 shares of Edgewise TherapeuticsSEC Form 430 September 2021Common Stock · traded 28 September 2021 · filed 30 September 2021
- ▼ sold on the open market 11,226 shares of Edgewise TherapeuticsSEC Form 430 September 2021Common Stock · traded 29 September 2021 · filed 30 September 2021
- ▼ sold on the open market 618 shares of Edgewise TherapeuticsSEC Form 430 September 2021Common Stock · traded 29 September 2021 · filed 30 September 2021
- ▼ sold on the open market 21,763 shares of Edgewise TherapeuticsSEC Form 427 September 2021Common Stock · traded 23 September 2021 · filed 27 September 2021
- ▼ sold on the open market 5,072 shares of Edgewise TherapeuticsSEC Form 427 September 2021Common Stock · traded 23 September 2021 · filed 27 September 2021
- ▼ sold on the open market 20,100 shares of Edgewise TherapeuticsSEC Form 427 September 2021Common Stock · traded 24 September 2021 · filed 27 September 2021
- ▼ sold on the open market 11,594 shares of Edgewise TherapeuticsSEC Form 427 September 2021Common Stock · traded 27 September 2021 · filed 27 September 2021
- ▼ sold on the open market 17 shares of Edgewise TherapeuticsSEC Form 427 September 2021Common Stock · traded 27 September 2021 · filed 27 September 2021
- was granted 120,000 shares of Edgewise Therapeutics (a derivative holding)SEC Form 419 August 2021Stock Option (Right to Buy) · traded 17 August 2021 · filed 19 August 2021
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.